 | • レポートコード：MRC2-11QY08692 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は膵炎治療薬のグローバル市場について調査・分析したレポートです。種類別（錠剤、カプセル）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別膵炎治療薬の競争状況、市場シェア ・世界の膵炎治療薬市場：種類別市場規模 2015年-2020年（錠剤、カプセル） ・世界の膵炎治療薬市場：種類別市場規模予測 2021年-2026年（錠剤、カプセル） ・世界の膵炎治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の膵炎治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の膵炎治療薬市場分析：米国、カナダ ・ヨーロッパの膵炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの膵炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の膵炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの膵炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、AbbVie Inc、Medinova、Mochida、Vital Nutrients、Chiesi、Freeda、Forest Pharmaceuticals、Megazyme、Aptalis、Janssen Pharmaceuticals、Changzhou Qianhong、Qijiang Pharmaceutical、Techpool、Haerbin Sanlian、Kinyond、Changzhou Siyao、Gloria、Qingdao Kang Yuan Pharmaceutical、Shanghai Mokai ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Pancreatitis Drugs Market
The global Pancreatitis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pancreatitis Drugs Scope and Market Size
Pancreatitis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatitis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pancreatitis Drugs market is segmented into
Tablets
Capsule
Segment by Application, the Pancreatitis Drugs market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional and Country-level Analysis
The Pancreatitis Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pancreatitis Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pancreatitis Drugs Market Share Analysis
Pancreatitis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pancreatitis Drugs business, the date to enter into the Pancreatitis Drugs market, Pancreatitis Drugs product introduction, recent developments, etc.
The major vendors covered:
GSK
AbbVie Inc
Medinova
Mochida
Vital Nutrients
Chiesi
Freeda
Forest Pharmaceuticals
Megazyme
Aptalis
Janssen Pharmaceuticals
Changzhou Qianhong
Qijiang Pharmaceutical
Techpool
Haerbin Sanlian
Kinyond
Changzhou Siyao
Gloria
Qingdao Kang Yuan Pharmaceutical
Shanghai Mokai
1 Study Coverage
1.1 Pancreatitis Drugs Product Introduction
1.2 Market Segments
1.3 Key Pancreatitis Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pancreatitis Drugs Market Size Growth Rate by Type
1.4.2 Tablets
1.4.3 Capsule
1.5 Market by Application
1.5.1 Global Pancreatitis Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pancreatitis Drugs Market Size, Estimates and Forecasts
2.1.1 Global Pancreatitis Drugs Revenue 2015-2026
2.1.2 Global Pancreatitis Drugs Sales 2015-2026
2.2 Global Pancreatitis Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pancreatitis Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pancreatitis Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pancreatitis Drugs Competitor Landscape by Players
3.1 Pancreatitis Drugs Sales by Manufacturers
3.1.1 Pancreatitis Drugs Sales by Manufacturers (2015-2020)
3.1.2 Pancreatitis Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Pancreatitis Drugs Revenue by Manufacturers
3.2.1 Pancreatitis Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Pancreatitis Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pancreatitis Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pancreatitis Drugs Revenue in 2019
3.2.5 Global Pancreatitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pancreatitis Drugs Price by Manufacturers
3.4 Pancreatitis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Pancreatitis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pancreatitis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Pancreatitis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pancreatitis Drugs Market Size by Type (2015-2020)
4.1.1 Global Pancreatitis Drugs Sales by Type (2015-2020)
4.1.2 Global Pancreatitis Drugs Revenue by Type (2015-2020)
4.1.3 Pancreatitis Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pancreatitis Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Pancreatitis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Pancreatitis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Pancreatitis Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pancreatitis Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pancreatitis Drugs Market Size by Application (2015-2020)
5.1.1 Global Pancreatitis Drugs Sales by Application (2015-2020)
5.1.2 Global Pancreatitis Drugs Revenue by Application (2015-2020)
5.1.3 Pancreatitis Drugs Price by Application (2015-2020)
5.2 Pancreatitis Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Pancreatitis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Pancreatitis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Pancreatitis Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pancreatitis Drugs by Country
6.1.1 North America Pancreatitis Drugs Sales by Country
6.1.2 North America Pancreatitis Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pancreatitis Drugs Market Facts & Figures by Type
6.3 North America Pancreatitis Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Pancreatitis Drugs by Country
7.1.1 Europe Pancreatitis Drugs Sales by Country
7.1.2 Europe Pancreatitis Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pancreatitis Drugs Market Facts & Figures by Type
7.3 Europe Pancreatitis Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pancreatitis Drugs by Region
8.1.1 Asia Pacific Pancreatitis Drugs Sales by Region
8.1.2 Asia Pacific Pancreatitis Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pancreatitis Drugs Market Facts & Figures by Type
8.3 Asia Pacific Pancreatitis Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pancreatitis Drugs by Country
9.1.1 Latin America Pancreatitis Drugs Sales by Country
9.1.2 Latin America Pancreatitis Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pancreatitis Drugs Market Facts & Figures by Type
9.3 Central & South America Pancreatitis Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pancreatitis Drugs by Country
10.1.1 Middle East and Africa Pancreatitis Drugs Sales by Country
10.1.2 Middle East and Africa Pancreatitis Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pancreatitis Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Pancreatitis Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Pancreatitis Drugs Products Offered
11.1.5 GSK Related Developments
11.2 AbbVie Inc
11.2.1 AbbVie Inc Corporation Information
11.2.2 AbbVie Inc Description and Business Overview
11.2.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AbbVie Inc Pancreatitis Drugs Products Offered
11.2.5 AbbVie Inc Related Developments
11.3 Medinova
11.3.1 Medinova Corporation Information
11.3.2 Medinova Description and Business Overview
11.3.3 Medinova Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Medinova Pancreatitis Drugs Products Offered
11.3.5 Medinova Related Developments
11.4 Mochida
11.4.1 Mochida Corporation Information
11.4.2 Mochida Description and Business Overview
11.4.3 Mochida Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mochida Pancreatitis Drugs Products Offered
11.4.5 Mochida Related Developments
11.5 Vital Nutrients
11.5.1 Vital Nutrients Corporation Information
11.5.2 Vital Nutrients Description and Business Overview
11.5.3 Vital Nutrients Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Vital Nutrients Pancreatitis Drugs Products Offered
11.5.5 Vital Nutrients Related Developments
11.6 Chiesi
11.6.1 Chiesi Corporation Information
11.6.2 Chiesi Description and Business Overview
11.6.3 Chiesi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Chiesi Pancreatitis Drugs Products Offered
11.6.5 Chiesi Related Developments
11.7 Freeda
11.7.1 Freeda Corporation Information
11.7.2 Freeda Description and Business Overview
11.7.3 Freeda Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Freeda Pancreatitis Drugs Products Offered
11.7.5 Freeda Related Developments
11.8 Forest Pharmaceuticals
11.8.1 Forest Pharmaceuticals Corporation Information
11.8.2 Forest Pharmaceuticals Description and Business Overview
11.8.3 Forest Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Forest Pharmaceuticals Pancreatitis Drugs Products Offered
11.8.5 Forest Pharmaceuticals Related Developments
11.9 Megazyme
11.9.1 Megazyme Corporation Information
11.9.2 Megazyme Description and Business Overview
11.9.3 Megazyme Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Megazyme Pancreatitis Drugs Products Offered
11.9.5 Megazyme Related Developments
11.10 Aptalis
11.10.1 Aptalis Corporation Information
11.10.2 Aptalis Description and Business Overview
11.10.3 Aptalis Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Aptalis Pancreatitis Drugs Products Offered
11.10.5 Aptalis Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Pancreatitis Drugs Products Offered
11.1.5 GSK Related Developments
11.12 Changzhou Qianhong
11.12.1 Changzhou Qianhong Corporation Information
11.12.2 Changzhou Qianhong Description and Business Overview
11.12.3 Changzhou Qianhong Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Changzhou Qianhong Products Offered
11.12.5 Changzhou Qianhong Related Developments
11.13 Qijiang Pharmaceutical
11.13.1 Qijiang Pharmaceutical Corporation Information
11.13.2 Qijiang Pharmaceutical Description and Business Overview
11.13.3 Qijiang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Qijiang Pharmaceutical Products Offered
11.13.5 Qijiang Pharmaceutical Related Developments
11.14 Techpool
11.14.1 Techpool Corporation Information
11.14.2 Techpool Description and Business Overview
11.14.3 Techpool Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Techpool Products Offered
11.14.5 Techpool Related Developments
11.15 Haerbin Sanlian
11.15.1 Haerbin Sanlian Corporation Information
11.15.2 Haerbin Sanlian Description and Business Overview
11.15.3 Haerbin Sanlian Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Haerbin Sanlian Products Offered
11.15.5 Haerbin Sanlian Related Developments
11.16 Kinyond
11.16.1 Kinyond Corporation Information
11.16.2 Kinyond Description and Business Overview
11.16.3 Kinyond Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Kinyond Products Offered
11.16.5 Kinyond Related Developments
11.17 Changzhou Siyao
11.17.1 Changzhou Siyao Corporation Information
11.17.2 Changzhou Siyao Description and Business Overview
11.17.3 Changzhou Siyao Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Changzhou Siyao Products Offered
11.17.5 Changzhou Siyao Related Developments
11.18 Gloria
11.18.1 Gloria Corporation Information
11.18.2 Gloria Description and Business Overview
11.18.3 Gloria Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Gloria Products Offered
11.18.5 Gloria Related Developments
11.19 Qingdao Kang Yuan Pharmaceutical
11.19.1 Qingdao Kang Yuan Pharmaceutical Corporation Information
11.19.2 Qingdao Kang Yuan Pharmaceutical Description and Business Overview
11.19.3 Qingdao Kang Yuan Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Qingdao Kang Yuan Pharmaceutical Products Offered
11.19.5 Qingdao Kang Yuan Pharmaceutical Related Developments
11.20 Shanghai Mokai
11.20.1 Shanghai Mokai Corporation Information
11.20.2 Shanghai Mokai Description and Business Overview
11.20.3 Shanghai Mokai Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Shanghai Mokai Products Offered
11.20.5 Shanghai Mokai Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pancreatitis Drugs Market Estimates and Projections by Region
12.1.1 Global Pancreatitis Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Pancreatitis Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Pancreatitis Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Pancreatitis Drugs Sales Forecast (2021-2026)
12.2.2 North America: Pancreatitis Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Pancreatitis Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Pancreatitis Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Pancreatitis Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Pancreatitis Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Pancreatitis Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pancreatitis Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pancreatitis Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pancreatitis Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pancreatitis Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Pancreatitis Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Pancreatitis Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Pancreatitis Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Pancreatitis Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pancreatitis Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pancreatitis Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pancreatitis Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pancreatitis Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pancreatitis Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pancreatitis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Pancreatitis Drugs Market Segments
Table 2. Ranking of Global Top Pancreatitis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pancreatitis Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Tablets
Table 5. Major Manufacturers of Capsule
Table 6. Global Pancreatitis Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 7. Global Pancreatitis Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 8. Global Pancreatitis Drugs Sales by Regions 2015-2020 (K Pcs)
Table 9. Global Pancreatitis Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Pancreatitis Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Pancreatitis Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 12. Global Pancreatitis Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Pancreatitis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Pancreatitis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatitis Drugs as of 2019)
Table 15. Pancreatitis Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Pancreatitis Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Pancreatitis Drugs Price (2015-2020) (USD/Pcs)
Table 18. Pancreatitis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Pancreatitis Drugs Product Type
Table 20. Date of International Manufacturers Enter into Pancreatitis Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Pancreatitis Drugs Sales by Type (2015-2020) (K Pcs)
Table 23. Global Pancreatitis Drugs Sales Share by Type (2015-2020)
Table 24. Global Pancreatitis Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Pancreatitis Drugs Revenue Share by Type (2015-2020)
Table 26. Pancreatitis Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 27. Global Pancreatitis Drugs Sales by Application (2015-2020) (K Pcs)
Table 28. Global Pancreatitis Drugs Sales Share by Application (2015-2020)
Table 29. North America Pancreatitis Drugs Sales by Country (2015-2020) (K Pcs)
Table 30. North America Pancreatitis Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Pancreatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Pancreatitis Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Pancreatitis Drugs Sales by Type (2015-2020) (K Pcs)
Table 34. North America Pancreatitis Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Pancreatitis Drugs Sales by Application (2015-2020) (K Pcs)
Table 36. North America Pancreatitis Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Pancreatitis Drugs Sales by Country (2015-2020) (K Pcs)
Table 38. Europe Pancreatitis Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Pancreatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Pancreatitis Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Pancreatitis Drugs Sales by Type (2015-2020) (K Pcs)
Table 42. Europe Pancreatitis Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Pancreatitis Drugs Sales by Application (2015-2020) (K Pcs)
Table 44. Europe Pancreatitis Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Pancreatitis Drugs Sales by Region (2015-2020) (K Pcs)
Table 46. Asia Pacific Pancreatitis Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Pancreatitis Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Pancreatitis Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Pancreatitis Drugs Sales by Type (2015-2020) (K Pcs)
Table 50. Asia Pacific Pancreatitis Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Pancreatitis Drugs Sales by Application (2015-2020) (K Pcs)
Table 52. Asia Pacific Pancreatitis Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Pancreatitis Drugs Sales by Country (2015-2020) (K Pcs)
Table 54. Latin America Pancreatitis Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Pancreatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Pancreatitis Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Pancreatitis Drugs Sales by Type (2015-2020) (K Pcs)
Table 58. Latin America Pancreatitis Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Pancreatitis Drugs Sales by Application (2015-2020) (K Pcs)
Table 60. Latin America Pancreatitis Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Pancreatitis Drugs Sales by Country (2015-2020) (K Pcs)
Table 62. Middle East and Africa Pancreatitis Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Pancreatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Pancreatitis Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Pancreatitis Drugs Sales by Type (2015-2020) (K Pcs)
Table 66. Middle East and Africa Pancreatitis Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Pancreatitis Drugs Sales by Application (2015-2020) (K Pcs)
Table 68. Middle East and Africa Pancreatitis Drugs Sales Market Share by Application (2015-2020)
Table 69. GSK Corporation Information
Table 70. GSK Description and Major Businesses
Table 71. GSK Pancreatitis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 72. GSK Product
Table 73. GSK Recent Development
Table 74. AbbVie Inc Corporation Information
Table 75. AbbVie Inc Description and Major Businesses
Table 76. AbbVie Inc Pancreatitis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. AbbVie Inc Product
Table 78. AbbVie Inc Recent Development
Table 79. Medinova Corporation Information
Table 80. Medinova Description and Major Businesses
Table 81. Medinova Pancreatitis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Medinova Product
Table 83. Medinova Recent Development
Table 84. Mochida Corporation Information
Table 85. Mochida Description and Major Businesses
Table 86. Mochida Pancreatitis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Mochida Product
Table 88. Mochida Recent Development
Table 89. Vital Nutrients Corporation Information
Table 90. Vital Nutrients Description and Major Businesses
Table 91. Vital Nutrients Pancreatitis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Vital Nutrients Product
Table 93. Vital Nutrients Recent Development
Table 94. Chiesi Corporation Information
Table 95. Chiesi Description and Major Businesses
Table 96. Chiesi Pancreatitis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Chiesi Product
Table 98. Chiesi Recent Development
Table 99. Freeda Corporation Information
Table 100. Freeda Description and Major Businesses
Table 101. Freeda Pancreatitis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Freeda Product
Table 103. Freeda Recent Development
Table 104. Forest Pharmaceuticals Corporation Information
Table 105. Forest Pharmaceuticals Description and Major Businesses
Table 106. Forest Pharmaceuticals Pancreatitis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Forest Pharmaceuticals Product
Table 108. Forest Pharmaceuticals Recent Development
Table 109. Megazyme Corporation Information
Table 110. Megazyme Description and Major Businesses
Table 111. Megazyme Pancreatitis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Megazyme Product
Table 113. Megazyme Recent Development
Table 114. Aptalis Corporation Information
Table 115. Aptalis Description and Major Businesses
Table 116. Aptalis Pancreatitis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Aptalis Product
Table 118. Aptalis Recent Development
Table 119. Janssen Pharmaceuticals Corporation Information
Table 120. Janssen Pharmaceuticals Description and Major Businesses
Table 121. Janssen Pharmaceuticals Pancreatitis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Janssen Pharmaceuticals Product
Table 123. Janssen Pharmaceuticals Recent Development
Table 124. Changzhou Qianhong Corporation Information
Table 125. Changzhou Qianhong Description and Major Businesses
Table 126. Changzhou Qianhong Pancreatitis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Changzhou Qianhong Product
Table 128. Changzhou Qianhong Recent Development
Table 129. Qijiang Pharmaceutical Corporation Information
Table 130. Qijiang Pharmaceutical Description and Major Businesses
Table 131. Qijiang Pharmaceutical Pancreatitis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Qijiang Pharmaceutical Product
Table 133. Qijiang Pharmaceutical Recent Development
Table 134. Techpool Corporation Information
Table 135. Techpool Description and Major Businesses
Table 136. Techpool Pancreatitis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Techpool Product
Table 138. Techpool Recent Development
Table 139. Haerbin Sanlian Corporation Information
Table 140. Haerbin Sanlian Description and Major Businesses
Table 141. Haerbin Sanlian Pancreatitis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 142. Haerbin Sanlian Product
Table 143. Haerbin Sanlian Recent Development
Table 144. Kinyond Corporation Information
Table 145. Kinyond Description and Major Businesses
Table 146. Kinyond Pancreatitis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 147. Kinyond Product
Table 148. Kinyond Recent Development
Table 149. Changzhou Siyao Corporation Information
Table 150. Changzhou Siyao Description and Major Businesses
Table 151. Changzhou Siyao Pancreatitis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 152. Changzhou Siyao Product
Table 153. Changzhou Siyao Recent Development
Table 154. Gloria Corporation Information
Table 155. Gloria Description and Major Businesses
Table 156. Gloria Pancreatitis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 157. Gloria Product
Table 158. Gloria Recent Development
Table 159. Qingdao Kang Yuan Pharmaceutical Corporation Information
Table 160. Qingdao Kang Yuan Pharmaceutical Description and Major Businesses
Table 161. Qingdao Kang Yuan Pharmaceutical Pancreatitis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 162. Qingdao Kang Yuan Pharmaceutical Product
Table 163. Qingdao Kang Yuan Pharmaceutical Recent Development
Table 164. Shanghai Mokai Corporation Information
Table 165. Shanghai Mokai Description and Major Businesses
Table 166. Shanghai Mokai Pancreatitis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 167. Shanghai Mokai Product
Table 168. Shanghai Mokai Recent Development
Table 169. Global Pancreatitis Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 170. Global Pancreatitis Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 171. Global Pancreatitis Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 172. Global Pancreatitis Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 173. North America: Pancreatitis Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 174. North America: Pancreatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Europe: Pancreatitis Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 176. Europe: Pancreatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Asia Pacific: Pancreatitis Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 178. Asia Pacific: Pancreatitis Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 179. Latin America: Pancreatitis Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 180. Latin America: Pancreatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Middle East and Africa: Pancreatitis Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 182. Middle East and Africa: Pancreatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 184. Key Challenges
Table 185. Market Risks
Table 186. Main Points Interviewed from Key Pancreatitis Drugs Players
Table 187. Pancreatitis Drugs Customers List
Table 188. Pancreatitis Drugs Distributors List
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Pancreatitis Drugs Product Picture
Figure 2. Global Pancreatitis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Tablets Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Pancreatitis Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Pancreatitis Drugs Report Years Considered
Figure 10. Global Pancreatitis Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Pancreatitis Drugs Sales 2015-2026 (K Pcs)
Figure 12. Global Pancreatitis Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Pancreatitis Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Pancreatitis Drugs Sales Market Share by Region in 2019
Figure 15. Global Pancreatitis Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Pancreatitis Drugs Revenue Market Share by Region in 2019
Figure 17. Global Pancreatitis Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Pancreatitis Drugs Revenue in 2019
Figure 19. Pancreatitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Pancreatitis Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Pancreatitis Drugs Sales Market Share by Type in 2019
Figure 22. Global Pancreatitis Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Pancreatitis Drugs Revenue Market Share by Type in 2019
Figure 24. Global Pancreatitis Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Pancreatitis Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Pancreatitis Drugs Sales Market Share by Application in 2019
Figure 27. Global Pancreatitis Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Pancreatitis Drugs Revenue Market Share by Application in 2019
Figure 29. North America Pancreatitis Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 30. North America Pancreatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Pancreatitis Drugs Sales Market Share by Country in 2019
Figure 32. North America Pancreatitis Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. U.S. Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Canada Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Pancreatitis Drugs Market Share by Type in 2019
Figure 38. North America Pancreatitis Drugs Market Share by Application in 2019
Figure 39. Europe Pancreatitis Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. Europe Pancreatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Pancreatitis Drugs Sales Market Share by Country in 2019
Figure 42. Europe Pancreatitis Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Germany Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. France Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. U.K. Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Italy Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Russia Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Pancreatitis Drugs Market Share by Type in 2019
Figure 54. Europe Pancreatitis Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Pancreatitis Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 56. Asia Pacific Pancreatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Pancreatitis Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Pancreatitis Drugs Revenue Market Share by Region in 2019
Figure 59. China Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. China Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Japan Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. South Korea Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. India Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Australia Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Taiwan Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Indonesia Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Thailand Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Malaysia Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Philippines Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Vietnam Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Pancreatitis Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Pancreatitis Drugs Market Share by Application in 2019
Figure 83. Latin America Pancreatitis Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 84. Latin America Pancreatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Pancreatitis Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Pancreatitis Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Mexico Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Brazil Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Argentina Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Pancreatitis Drugs Market Share by Type in 2019
Figure 94. Latin America Pancreatitis Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Pancreatitis Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 96. Middle East and Africa Pancreatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Pancreatitis Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Pancreatitis Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Turkey Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Saudi Arabia Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Pancreatitis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. U.A.E Pancreatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Pancreatitis Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Pancreatitis Drugs Market Share by Application in 2019
Figure 107. North America Pancreatitis Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 108. North America Pancreatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Pancreatitis Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. Europe Pancreatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Pancreatitis Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Asia Pacific Pancreatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Pancreatitis Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Latin America Pancreatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Pancreatitis Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Middle East and Africa Pancreatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
水虫薬の世界市場（～2026年） Athlete's foot, known medically as tinea pedis, is a common skin infection of the feet caused by fungus.Signs and symptoms often include itching, scaling, cracking and redness. In rare cases the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the…- 非アルコール性脂肪性肝炎（NASH）治療薬の世界市場（～2026年） Nonalcoholic steatohepatitis is a form of liver disease that develops in patients who are not alcoholic. The major feature in NASH is fat deposition in the liver, along with inflammation and damage to the liver. Most patients with NASH are not aware that they are suffering from a liver problem. Howe…
- 喘息治療薬の世界市場（～2026年） Market Analysis and Insights: Global Asthma Treatment Drugs Market The global Asthma Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Asthma Treatment Drugs Scope and Market Size Asthma Treatment Drugs m…
- 外陰部痛治療薬の世界市場（～2026年） Market Analysis and Insights: Global Vulvodynia Treatment Drugs Market The global Vulvodynia Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vulvodynia Treatment Drugs Scope and Market Size Vulvodynia T…
- 市販薬（OTC）の世界市場（～2026年） Market Analysis and Insights: Global Over-The-Counter (OTC) Drugs Market The global Over-The-Counter (OTC) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Over-The-Counter (OTC) Drugs Scope and Market Size Over-T…